
Areas of Expertise
Conditions I Treat
- Graft-versus-host-disease (GVHD)
- Leukemia
- Blood, bone marrow, and hematologic cancers and conditions
My Specialties
- Stem cell transplant
- Bone marrow transplant
- Clinical trials
Get to Know Me
I am a board-certified hematologist and oncologist with special expertise in using hematopoietic (blood-forming) stem cell transplantation to treat adults with blood cancers. I am part of a group of hematologists and transplant specialists who work together in a coordinated and collaborative manner to provide our patients with the best cancer care.
Read more
My particular interest is in expanding transplant access, particularly for patients from racial and ethnic minorities who may have lower chances of finding a compatible donor. To do so, we can use alternative stem cell sources, such as cord blood (blood collected from the umbilical cord and placenta of healthy newborns) and mismatched donors (donors whose stem cells do not match the patient’s).
I investigate ways to make transplant safer by reducing the risk of related issues, including a potentially life-threatening complication known as graft-versus-host disease (GVHD). GVHD happens when donor immune cells identify the patient’s tissue as foreign and begin to attack it. As a clinical researcher, I am investigating novel therapies to prevent and treat acute and chronic GVHD.
I see patients with a variety of blood cancers who need a stem cell transplant, including patients with acute leukemia, myelodysplastic syndromes (MDS), lymphoma, and myeloproliferative neoplasms (MPN). Additionally, I lead a multidisciplinary GVHD clinic in the Bone Marrow Transplant Service for the care of adults who develop this complication. The goal of my practice is to provide customized care with a dedicated team of advanced care providers, nurses, office assistants, pharmacists, and social workers, while providing access to novel therapies through clinical trials.
A bone marrow transplant specialist is a doctor with special training in bone marrow transplants.
- Co-Chair, Center for Hematologic Malignancies Translational Research Council
- Director, Graft-Versus-Host Disease Program
Conditions I Treat
- Graft-versus-host-disease (GVHD)
- Leukemia
- Blood, bone marrow, and hematologic cancers and conditions
- Myelodysplastic syndrome (MDS)
- Lymphoma
- Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders
My Specialties
- Stem cell transplant
- Bone marrow transplant
- Clinical trials
Education
- MD, Universidad Central de Venezuela
- MS, Clinical and Translational Cancer Research, The Gerstner Sloan Kettering Graduate School of Biomedical Sciences
Residencies
- Internal Medicine, Albert Einstein College of Medicine
Fellowships
- Hematology/Oncology - New York Medical College
- Bone Marrow Transplantation - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Awards and Honors
- Incyte Ingenuity Award in GVHD (2024 & 2021)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

Contact and Location
Dr. Ponce sees patients at one location.






Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Ponce
- A Phase 2 Study of Axatilimab Plus Ruxolitinib in Adults and Children With Chronic Graft-Versus-Host Disease
- Clinical Trials Co-Investigated by Dr. Ponce
- A Phase II Study of Photobiomodulation Therapy in Children and Adults with Oral Graft-versus-Host Disease after Stem Cell Transplantation

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Andrew C. Harris, Alina Markova, Sean Devlin, Amandeep Singh, Pamela Susman, Soni Brown, Christine Grasso, Christian Custodio, Cherry Estilo, Katarzyna Ibanez, Michelle Myers, Grigory Syrkin, SaeHee Yom, Miguel-Angel Perales, Doris M. Ponce, Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic, Transplantation and Cellular Therapy, 2024, ISSN 2666-6367.
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
4.9 61 reviews
- 4.8 Provider's Explanations Easy to Understand
- 4.8 Trusts Provider with Care
- 4.8 Provider Listened Carefully
- 4.9 Likelihood of Recommending Provider
It was exactly what it needed to be.
Hi, this is [patient name removed]. Dr. Ponce and her nurse, Sarah, are wonderful. They've been excellent through all the care I've received from them. Dr. Ponce has been so beneficial through my struggles with my cancer and since transplant and has helped with a lot of the chemo drugs and advocated for me to stay on some of them and to get on some of them. So it's been a wonderful experience with us over the last 10 years. Thank you so much.
I appreciate the continued care all round , thank you.
Yes, the doctor was very good. We understood everything that she was saying. Only thing is that there were several times where it was very hard to hear her. She had a mask on and she was very soft spoken. Other than that, it was great.
Dr. Ponce and her team have been very supportive, and I have trusted her's and her team's judgment and recommendations.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Doris M. Ponce discloses the following relationships and financial interests:
-
CareDx
Professional Services and Activities -
Evive Biotech
Professional Services and Activities (Uncompensated) -
Guidepoint Global Advisors
Professional Services and Activities (Uncompensated)
-
Incyte
Professional Services and Activities -
OncLive
Professional Services and Activities -
Sanofi-Aventis U.S. LLC
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.